Skip to main content
. Author manuscript; available in PMC: 2015 Mar 13.
Published in final edited form as: Brain Res. 2014 Jan 20;1552:55–63. doi: 10.1016/j.brainres.2014.01.012

Figure 4.

Figure 4

Tumors alter LPS-induced indolamine 2,3-deoxygenase (IDO) mRNA expression in the brain. Mean ± SEM Ido mRNA in the (A) hippocampus, (B) hypothalamus, and (C) frontal cortex of rats with or without mammary carcinomas 4 or 24 h after i.p. injection with LPS or 24 h after i.p. injection with saline (n=7–12 rat/treatment). Ido was undetectable for the majority 72% of samples in the 24 h post-LPS groups (see Methods). *p ≤ 0.05 between tumor and no tumor values #p ≤ 0.05 between LPS and respective saline values